Thursday, March 29, 2012

Gene-Therapy Company Files Chapter 7 Bankruptcy

Neurologix Inc., a developer of gene therapies for disorders of the brain and central nervous system, has recently filed for Chapter 7 in U.S. Bankruptcy Court in Wilmington, Delaware. The New Jersey-based company lists assets of $1.2 million and liabilities of $12.9 million in its bankruptcy filing.
According to an article on by Dawn McCarty, Neurologix hired Global Resource Partners Inc. to provide consulting and financial advice following the resignation of Chief Financial Officer, Marc Panoff.
Neurologix Inc. is owned by Corriente Advisors LLC, General Electric Pension Trust, Palisades Private Partnership LP, DaimlerChrysler Corp. LLC Master Retirement Trust, and ATEC Trust.
The Macey Bankruptcy Law attorneys are an unsurpassed staff of the most knowledgeable consumer bankruptcy attorneys in the country, representing tens of thousands of new clients each year in Chapter 7 and Chapter 13 consumer bankruptcy. Call us toll-free at 800-260-2402 Monday through Saturday as well as evenings to arrange your initial free consultation and log onto our interactive website, Do it for yourself; do it for your family; do it today.

No comments:

Post a Comment